Oncogene - Table of Contents alert Volume 32 Issue 13

Advertisement Finally! Antibodies you can trust. Diagenode has revolutionized immunoprecipitation with a novel, rigorous antibody classification system. Since 2003, we are the only company to have worked closely with experts in the epigenetics community to develop the absolute best epigenetics reagents and antibodies. Have confidence in the antibodies you choose. Achieve unparalleled ChIP and ChIP-seq results with antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 32, Issue 13 (March 2013) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Free articles! Stay up to date with the latest research in Leukemia. - Study of natural background radiation and the incidence of childhood leukaemia and other cancers in Great Britain during 1980–2006 - Hematopoietic stem cell mobilization: updated conceptual renditions - The ASXL–BAP1 axis: new factors in myelopoiesis, cancer and epigenetics SIGN UP for the Leukemia alert today.   Review Top Genome-wide mechanisms of Smad binding Open M Morikawa, D Koinuma, K Miyazono and C-H Heldin Oncogene 2013 32: 1609-1615; advance online publication, May 21, 2012; 10.1038/onc.2012.191 Abstract | Full Text Original Articles Top HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer K Kim, I Jutooru, G Chadalapaka, G Johnson, J Frank, R Burghardt, S Kim and S Safe Oncogene 2013 32: 1616-1625; advance online publication, May 21, 2012; 10.1038/onc.2012.193 Abstract | Full Text Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein P Wimmer, P Blanchette, S Schreiner, W Ching, P Groitl, J Berscheminski, P E Branton, H Will and T Dobner Oncogene 2013 32: 1626-1637; advance online publication, May 21, 2012; 10.1038/onc.2012.187 Abstract | Full Text Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer G Sutendra, P Dromparis, A Kinnaird, T H Stenson, A Haromy, J M R Parker, M S McMurtry and E D Michelakis Oncogene 2013 32: 1638-1650; advance online publication, May 21, 2012; 10.1038/onc.2012.198 Abstract | Full Text Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway T Palumbo, F R Faucz, M Azevedo, P Xekouki, D Iliopoulos and C A Stratakis Oncogene 2013 32: 1651-1659; advance online publication, May 21, 2012; 10.1038/onc.2012.190 Abstract | Full Text The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation Z Liu, S M Zanata, J Kim, M A Peterson, D Di Vizio, L R Chirieac, S Pyne, M Agostini, M R Freeman and M Loda Oncogene 2013 32: 1660-1669; advance online publication, June 18, 2012; 10.1038/onc.2012.188 Abstract | Full Text BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia I Kuroda, T Inukai, X Zhang, J Kikuchi, Y Furukawa, A Nemoto, K Akahane, K Hirose, H Honna-Oshiro, K Goi, K Kagami, H Yagita, T Tauchi, Y Maeda and K Sugita Oncogene 2013 32: 1670-1681; advance online publication, June 4, 2012; 10.1038/onc.2012.186 Abstract | Full Text LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump S Fan, Y Niu, N Tan, Z Wu, Y Wang, H You, R Ke, J Song, Q Shen, W Wang, G Yao, H Shu, H Lin, M Yao, Z Zhang, J Gu and W Qin Oncogene 2013 32: 1682-1690; advance online publication, May 14, 2012; 10.1038/onc.2012.183 Abstract | Full Text The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation C M Das, P Taylor, M Gireud, A Singh, D Lee, G Fuller, L Ji, J Fangusaro, V Rajaram, S Goldman, C Eberhart and V Gopalakrishnan Oncogene 2013 32: 1691-1701; advance online publication, June 4, 2012; 10.1038/onc.2012.182 Abstract | Full Text The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin Y Ye, H Tian, A R Lange, K Yearsley, F M Robertson and S H Barsky Oncogene 2013 32: 1702-1713; advance online publication, May 14, 2012; 10.1038/onc.2012.180 Abstract | Full Text The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family N Skrypek, B Duchêne, M Hebbar, E Leteurtre, I van Seuningen and N Jonckheere Oncogene 2013 32: 1714-1723; advance online publication, May 14, 2012; 10.1038/onc.2012.179 Abstract | Full Text Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma X Xue, W Gao, B Sun, Y Xu, B Han, F Wang, Y Zhang, J Sun, J Wei, Z Lu, Y Zhu, Y Sato, Y Sekido, Y Miao and Y Kondo Oncogene 2013 32: 1724-1734; advance online publication, May 21, 2012; 10.1038/onc.2012.177 Abstract | Full Text Short Communication Top The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation S Castillo-Lluva, C-T Tan, M Daugaard, P H B Sorensen and A Malliri Oncogene 2013 32: 1735-1742; advance online publication, May 21, 2012; 10.1038/onc.2012.189 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.